# Electrical Vestibular Nerve Stimulation (VeNS) Compared to Sham Control As a Means of Improving Glycemic Control in Adults with Type 2 Diabetes Mellitus

Study · id `cardio:ct-nct04595968` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04595968](<https://clinicaltrials.gov/study/NCT04595968>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04595968

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 267 participants.

## Technical summary

Registry record NCT04595968. Randomized; triple masking; primary purpose treatment. Start 2021-05-21 (actual); primary completion 2024-08-06 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 267 participants (enrolled count; ClinicalTrials.gov record NCT04595968, source copy `cardio:ctgov-nct04595968-2024-09-19`, retrieved 2026-10-26)
- Started: 2021-05-21 (actual) (ClinicalTrials.gov record NCT04595968, source copy `cardio:ctgov-nct04595968-2024-09-19`, retrieved 2026-10-26)
- Primary completion: 2024-08-06 (actual) (ClinicalTrials.gov record NCT04595968, source copy `cardio:ctgov-nct04595968-2024-09-19`, retrieved 2026-10-26)
- Completion: 2024-08-06 (actual) (ClinicalTrials.gov record NCT04595968, source copy `cardio:ctgov-nct04595968-2024-09-19`, retrieved 2026-10-26)
- Countries: United States; Ireland (ClinicalTrials.gov record NCT04595968, source copy `cardio:ctgov-nct04595968-2024-09-19`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04595968-2024-09-19`, retrieved 2026-10-26)

## The registry's words

- Brief title: Electrical Vestibular Nerve Stimulation (VeNS) Compared to Sham Control As a Means of Improving Glycemic Control in Adults with Type 2 Diabetes Mellitus
- Condition: Type 2 Diabetes
- Intervention (Device): Vestal DM Active device
- Intervention (Behavioral): Lifestyle modification
- Intervention (Device): Vestal DM Sham device
- Lead sponsor: Neurovalens Ltd.
- Lead sponsor class: INDUSTRY
- Collaborator: University College Dublin
- Collaborator class: OTHER
- Collaborator: CS Lifescience
- Collaborator class: UNKNOWN
- Collaborator: Clinical Trial Mentors
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as a collaborator: University College Dublin (`cardio:org-university-college-dublin`)

## Provenance

Content hash: 2410735336708cfce1472713a93cf94b0257254f198b4d75fa14889ae823387f
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
